HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prospects for the use of spherical gold nanoparticles in immunization.

Abstract
Recent years have seen extremely fast development of new viral nanovaccines and diagnostic agents using nanostructures prepared by biological and chemical synthesis. We used spherical gold nanoparticles (average diameter, 15 nm) as a platform for the antigen for swine transmissible gastroenteritis virus (TGEV). The literature data demonstrate that immunization of animals with the TGEV antigen coupled to gold nanoparticles (GNPs) not only activates antigen-presenting cells but also increases the proliferative activity of splenic lymphoid (antibody-forming) cells. The contents of γ-IFN, IL-1β, and IL-6 in animals immunized with GNP-antigen conjugates were found to be higher than those in intact animals or in animals given the antigen alone. The increased concentration of IL-1β in the immunized animals directly correlated with the activity of macrophages and stimulated B cells, which produce this cytokine when activated. The increased concentration of IL-6 indicates that the injected preparations are stimulatory to cellular immunity. Immunization with the TGEV antigen conjugated to GNPs as a carrier activates the respiratory activity of lymphoid cells and peritoneal macrophages, which is directly related to their transforming activity and to the activation of antibody generation. Furthermore, the use of this conjugate allows marked improvement of the structure of the animals' immune organs and restores the morphological-functional state of these organs. The microanatomical changes (increased number of follicles) indicate the activation of the B-dependent zone of the spleen and, consequently, the development of a humoral-type immunological reaction. The degradative processes observed in the animals immunized with TGEV antigen alone are evidence of weak resistance to pathogen attack. These results can be used to develop vaccines against this infection by employing TGEV antigen coupled to gold nanoparticles as a carrier.
AuthorsSergey A Staroverov, Alexei A Volkov, Pavel V Mezhenny, Ivan Yu Domnitsky, Alexander S Fomin, Sergey V Kozlov, Lev A Dykman, Olga I Guliy
JournalApplied microbiology and biotechnology (Appl Microbiol Biotechnol) Vol. 103 Issue 1 Pg. 437-447 (Jan 2019) ISSN: 1432-0614 [Electronic] Germany
PMID30402771 (Publication Type: Journal Article)
Chemical References
  • Antigens, Viral
  • Drug Carriers
  • Gold
  • Interferon-gamma
Topics
  • Animals
  • Antigens, Viral (chemistry)
  • Drug Carriers (administration & dosage, pharmacology)
  • Gold
  • Guinea Pigs
  • Immunization (methods)
  • Interferon-gamma (metabolism)
  • Macrophages, Peritoneal (immunology)
  • Male
  • Metal Nanoparticles (administration & dosage, chemistry)
  • Spleen (cytology, immunology)
  • Transmissible gastroenteritis virus (genetics, immunology, pathogenicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: